BEIJING, April 28,
2022 /PRNewswire/ -- Fuwei Films (Holdings) Co.,
Ltd. (Nasdaq: FFHL) ("Fuwei Films" or the "Company"), a
manufacturer and distributor of high-quality BOPET plastic films in
China, today announced its
financial results for the fourth quarter and full year ended
December 31, 2021.
4Q 2021 Highlights
- Net revenues were RMB92.6 million
or US$14.5 million
- Sales of specialty films were RMB71.1
million or US$11.2 million, up
14.1% year-over-year
- Gross margin was 30.8%, down from 42.2% a year ago
- Net income attributable to the Company was RMB11.4 million or US$1.8
million
- Basic and diluted earnings per share was RMB3.48 or US$0.55
Full Year 2021 Highlights
- Net revenues were RMB396.8
million or US$62.3
million
- Sales of specialty films were RMB277.3
million or US$43.5 million, up
35.5% year-over-year
- Net income attributable to the Company was RMB89.2 million or US$14.0
million, up from a net income of RMB19.6 million in 2020
- Basic and diluted earnings per share was RMB27.32 or US$4.29, up from a profit per share of
RMB6.00 a year ago
- Net cash provided by operating activities was RMB79.9 million or US$12.5
million, compared to RMB117.5
million a year ago
"In 2021, our revenues and gross margins continued to grow.
Sales of specialty films increased by 35.5% year-over-year and
accounted for 69.9% of our total revenues for the year. Our gross
margin was 37.5% in 2021. We are encouraged by positive trends
recorded in both revenues and gross margins, which we expect to
enable us to better navigate the industrial and economic landscape
ahead. We believe that our focus on innovation will allow the
Company to expand end-user product applications, attract new
clients, and expand relationships with existing customers,"
commented Mr. Lei Yan, CEO and Chairman of the Company.
Fourth Quarter 2021 Results
Revenues for the fourth quarter of 2021 were RMB92.6 million or US$14.5
million, compared with RMB86.4
million in the fourth quarter of 2020, an increase of
RMB6.2 million, or 7.2%. Sales volume
accounted for an increase of RMB0.6
million, while the increase in average sales price resulted
in an increase of RMB5.6 million.
Sales of specialty films for the fourth quarter of 2021 were
RMB71.1 million or US$11.2 million, accounting for 76.8% of total
revenues, compared with RMB62.3
million or 72.1% of total revenue in the fourth quarter of
2020. Higher sales volume accounted for an increase of RMB5.5 million, while the rise in average sales
price resulted in an increase of RMB3.3
million.
The following is a breakdown of commodity and specialty film
sales for the three-month periods ended December 31, 2021, and 2020 (amounts in
thousands):
|
|
Three months period
ended
|
|
|
December 31,
2021
|
% of Total
|
December 31,
2020
|
% of Total
|
|
|
RMB
|
US$
|
RMB
|
Stamping and transfer
film
|
|
13,240
|
2,077
|
14.2%
|
15,193
|
17.6%
|
Printing
film
|
|
3,752
|
589
|
4.1%
|
4,117
|
4.8%
|
Metallized
film
|
|
802
|
126
|
0.9%
|
815
|
0.9%
|
Specialty
film
|
|
71,064
|
11,151
|
76.8%
|
62,285
|
72.1%
|
Base film for other
applications
|
|
3,726
|
585
|
4.0%
|
3,940
|
4.6%
|
|
|
|
|
|
|
|
Total
|
|
92,584
|
14,528
|
100%
|
86,350
|
100%
|
Sales in China for the fourth
quarter of 2021 were RMB86.6 million,
or US$13.6 million,
representing 93.6% of total revenues, compared with RMB80.5 million or 93.2% of total revenues
recorded in the fourth quarter of 2020. Higher sales volume
accounted for an increase of RMB0.3
million, while the rise in average sales price explained the
increase of RMB5.8 million.
Overseas sales for the fourth quarter of 2021 amounted to
RMB5.9 million or US$0.9 million, representing 6.4% of total
revenues, compared with RMB5.9
million or 6.8% of total revenues in the fourth quarter of
2020.
The following is a breakdown of domestic versus overseas sales
for the three-month periods ended December
31, 2021, and 2020 (amounts in thousands):
|
|
Three-month period
ended
|
|
|
December 31,
2021
|
% of Total
|
December 31,
2020
|
% of Total
|
|
|
RMB
|
US$
|
RMB
|
Sales in
China
|
|
86,636
|
13,595
|
93.6%
|
80,500
|
93.2%
|
Sales in other
countries
|
|
5,948
|
933
|
6.4%
|
5,850
|
6.8%
|
|
|
|
|
|
|
|
Total
|
|
92,584
|
14,528
|
100%
|
86,350
|
100%
|
Gross profit for the fourth quarter of 2021 was RMB28.5 million or US$4.5
million, representing a gross margin of 30.8%, compared with
a gross profit of RMB36.5 million, or
a gross margin of 42.2% in the fourth quarter of 2020.
Operating expenses for the fourth quarter of 2021 totaled
RMB17.9 million or US$2.8 million, compared with RMB60.6 million in the fourth quarter of
2020.
Net income attributable to the Company for the fourth quarter of
2021 was RMB11.4 million or
US$1.8 million, compared with a net
loss of RMB20.9 million in the fourth
quarter of 2020.
Basic and diluted earnings per share was RMB3.48 or US$0.55,
compared with basic and diluted loss per share of RMB6.39 in the fourth quarter of 2020.
2021 Full Year Results
During the fiscal year ended December 31,
2021, net revenues reached RMB396.8
million (US$62.3 million),
compared to RMB336.8 million in 2020,
representing an increase of RMB60.0
million, or 17.8%.
In 2021, sales of specialty films were RMB277.3 million (US$43.5
million), accounting for 69.9% of our total revenues as
compared to RMB204.7 million, or
60.8% in 2020, representing an increase of RMB72.6 million, or 35.5% above those recorded in
2020. Higher sales volume led to an increase of RMB59.0 million, and an RMB13.6 million increase from the rise in average
sales price.
Overseas sales were RMB39.4
million (US$6.2 million) or
9.9% of total revenues, compared with RMB27.0 million or 8.0% of total revenues in
2020. The rise in average sales price caused an increase of
RMB2.5 million, and the higher sales
volume explained the RMB9.9 million
increase.
The following is a breakdown of domestic versus overseas sales
for the years ended December 31,
2021, and 2020 (amounts in thousands):
|
For the year ended
December 31,
|
|
|
2021
|
% of Total
|
2020
|
% of Total
|
|
|
RMB
|
US$
|
RMB
|
Sales in
China
|
|
357,396
|
56,083
|
90.1%
|
309,801
|
92.0%
|
Sales in other
countries
|
|
39,403
|
6,183
|
9.9%
|
26,954
|
8.0%
|
|
|
396,799
|
62,266
|
100.0%
|
336,755
|
100.0%
|
Our gross profit for the year ended December 31, 2021, was RMB148.9 million (US$23.4
million), up from RMB 136.7
million in 2020. Our average unit sales price rose 11.0%
when compared to last year. The unit sales cost increased 16.7% due
to the higher raw materials prices. Consequently, the increase in
cost of goods sold per unit exceeded that of sales price during
2021 compared with 2020, contributing to the decrease in our gross
margin. Our gross margin was 37.5% for the year 2021, compared to a
gross margin of 40.6% in 2020.
Our operating expenses during the year ended December 31, 2021, were RMB54.1 million (US$8.5
million), a decrease of RMB61.2
million, or 53.1%, as compared to 2020. The decrease was
mainly due to the reduction in loss on impairment of assets held
for sale and depreciation of property, plant, and equipment.
Net income attributable to the Company for the full year of 2021
was RMB89.2 million or US$14.0 million, up from a net profit
attributable to the Company of RMB19.6
million in 2020.
Basic and diluted earnings per share for the year ended
December 31, 2021, was RMB27.32 or US$4.29, up from a profit per share of
RMB6.00 a year ago.
Net cash provided by operating activities was RMB79.9 million or US$12.5
million for the year ended December
31, 2021, as compared to net cash provided by operating
activities of RMB117.5 million for
the year ended December 31, 2020.
Cash and cash equivalents on December 31,
2021 amounted to RMB250.6
million or US$39.3 million,
compared with RMB113.4 million as of
December 31, 2020.
About Fuwei Films
Fuwei Films conducts its business through its wholly-owned
subsidiary, Fuwei Films (Shandong)
Co., Ltd. ("Fuwei Shandong"). Fuwei Shandong develops,
manufactures, and distributes high-quality plastic films using the
biaxial oriented stretch technique, otherwise known as BOPET film
(biaxially-oriented polyethylene terephthalate). Fuwei's BOPET film
is widely used for packaging food, medicine, cosmetics, tobacco,
and alcohol, as well as in the imaging, electronics, and magnetic
products industries.
Safe Harbor
This press release contains information that constitutes
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995
and are subject to risks. Risk factors that could contribute to
such differences include those matters more fully disclosed in the
Company's reports filed with the U.S. Securities and Exchange
Commission which, among other things, include significant
competition in the BOPET film industry, especially the significant
oversupply of BOPET films resulting from the rapid growth of the
Chinese BOPET industry capacity, changes in the international
market and trade barriers, especially the adverse impact of the
antidumping investigation and imposition of an anti-dumping duty on
imports of the BOPET films originating from the People's
Republic of China ("China")
conducted by certain main importing countries; fluctuations of RMB
exchange rate, the reduce in demand for the Company's products or
the loss of main customers which may result in the decrease of
sales, and negatively influencing the Company's financial
performance, uncertainty as to the future profitability,
uncertainty as to the Company's ability to successfully obtain
additional funds to meet the working capital needs of the new BOPET
production line, uncertainty as to the Company's ability to
continuously develop new BOPET film products to be produced by the
third production line and keep up with changes in BOPET film
technology, risks associated with possible defects and errors in
its products including complaints and claims from clients,
uncertainty as to its ability to protect and enforce its
intellectual property rights, uncertainty as to its ability to
attract and retain qualified executives and personnel, and
uncertainty in acquiring raw materials on time and on acceptable
terms, particularly in light of the volatility in the prices of
petroleum products in recent years, instability of power and energy
supply, uncertainty around coronavirus (COVID-19) outbreak and the
effects of government and other measures seeking to contain its
spread; risks related to an economic downturn or recession in
the United States and in other
countries around the world; and changes in political, business, and
economic conditions, and the uncertainty regarding the future
operation of the Company in connection with the changes in the
labor law in China, the measures taken by the Chinese
government to save energy and reduce emissions, and the complaints
from nearby residents and local government about the noise caused
by our production as well as the uncertainty of the impact of major
shareholder transfer that have substantial influence over the
Company and the Company's business operation including possible
overlap of our BOPET products, customers and market orientation
with an BOPET film manufacturer, which is controlled by the same
individual who has control over the shares of our major
shareholder. The forward-looking information provided herein
represents the Company's estimates as of the date of the press
release, and subsequent events and developments may cause the
Company's estimates to change. The Company specifically disclaims
any obligation to update the forward-looking information in the
future. Therefore, this forward-looking information should not be
relied upon as representing the Company's estimates of its future
financial performance as of any date subsequent to the date of this
press release. Actual results of our operations may differ
materially from the information contained in the forward-looking
statements as a result of the risk factors.
Financial Tables Follow
FUWEI FILMS
(HOLDINGS) CO., LTD, and SUBSIDIARIES
|
|
CONSOLIDATED BALANCE SHEETS
|
As of
December 31, 2021, and 2020
|
(amounts in
thousands, except share and per share data)
|
|
|
|
|
|
December 31, 2021
|
|
December 31, 2020
|
|
|
|
|
RMB
|
|
US$
|
|
RMB
|
ASSETS
|
|
|
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
|
|
250,608
|
|
39,326
|
|
113,423
|
Restricted
cash
|
|
|
|
28,294
|
|
4,440
|
|
7,500
|
Accounts and bills
receivable, net
|
|
|
|
29,225
|
|
4,586
|
|
32,393
|
Inventories
|
|
|
|
35,456
|
|
5,564
|
|
25,436
|
Advance to
suppliers
|
|
|
|
7,933
|
|
1,245
|
|
7,359
|
Prepayments and other
receivables
|
|
|
|
1,199
|
|
188
|
|
1,103
|
Assets held for
sale
|
|
|
|
0
|
|
0
|
|
122,919
|
Deferred tax assets –
current
|
|
|
|
1,144
|
|
180
|
|
6,947
|
Total current
assets
|
|
|
|
353,859
|
|
55,529
|
|
317,080
|
|
|
|
|
|
|
|
|
|
Property, plant and
equipment, net
|
|
|
|
106,928
|
|
16,779
|
|
111,308
|
Construction in
progress
|
|
|
|
0
|
|
0
|
|
—
|
Lease prepayments,
net
|
|
|
|
14,685
|
|
2,304
|
|
15,219
|
Advance to suppliers -
long term, net
|
|
|
|
0
|
|
0
|
|
1,542
|
Deferred tax assets -
non-current
|
|
|
|
227
|
|
36
|
|
507
|
Total
assets
|
|
|
|
475,699
|
|
74,648
|
|
445,656
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
|
|
Short-term
loans
|
|
|
|
65,000
|
|
10,200
|
|
65,000
|
Due to related
parties
|
|
|
|
0
|
|
0
|
|
73,571
|
Accounts
payables
|
|
|
|
22,616
|
|
3,549
|
|
25,730
|
Notes
payable
|
|
|
|
50,126
|
|
7,866
|
|
15,000
|
Advance from
customers
|
|
|
|
7,672
|
|
1,204
|
|
9,297
|
Accrued expenses and
other payables
|
|
|
|
11,479
|
|
1,801
|
|
27,400
|
Total current
liabilities
|
|
|
|
156,893
|
|
24,620
|
|
215,998
|
Deferred tax
liabilities
|
|
|
|
1,789
|
|
281
|
|
1,854
|
Total
liabilities
|
|
|
|
158,682
|
|
24,901
|
|
217,852
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
Shareholders'
equity
|
|
|
|
|
|
|
|
|
Registered capital(of
US$0.519008 par value; 5,000,000 shares authorized; 3,265,837
issued and outstanding)
|
|
|
|
13,323
|
|
2,091
|
|
13,323
|
|
|
|
|
|
|
|
|
|
Additional paid-in
capital
|
|
|
|
311,907
|
|
48,945
|
|
311,907
|
Statutory
reserve
|
|
|
|
37,441
|
|
5,875
|
|
37,441
|
Retained
earnings
|
|
|
|
(46,494)
|
|
(7,296)
|
|
(135,707)
|
Cumulative translation
adjustment
|
|
|
|
840
|
|
132
|
|
840
|
Total shareholders'
equity
|
|
|
|
317,017
|
|
49,747
|
|
227,804
|
Total
equity
|
|
|
|
317,017
|
|
49,747
|
|
227,804
|
Total liabilities
and equity
|
|
|
|
475,699
|
|
74,648
|
|
445,656
|
FUWEI FILMS
(HOLDINGS) CO., LTD, and SUBSIDIARIES
|
|
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
|
For the Years
Ended December 31, 2021, 2020 and 2019
|
(amounts in thousands,
except share and per share data)
|
|
|
|
|
|
The Year Ended December 31,
|
|
|
|
|
2021
|
|
2020
|
|
2019
|
|
|
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
Net sales
|
|
|
|
396,799
|
|
62,266
|
|
336,755
|
|
335,620
|
Cost of
sales
|
|
|
|
247,902
|
|
38,901
|
|
200,056
|
|
252,010
|
Gross profit
|
|
|
|
148,897
|
|
23,365
|
|
136,699
|
|
83,610
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
|
Selling
expenses
|
|
|
|
20,706
|
|
3,249
|
|
17,483
|
|
13,721
|
Administrative
expenses
|
|
|
|
33,424
|
|
5,245
|
|
59,865
|
|
46,794
|
Loss on assets held for
sale
|
|
|
|
0
|
|
0
|
|
37,951
|
|
—
|
Total operating
expenses
|
|
|
|
54,130
|
|
8,494
|
|
115,299
|
|
60,515
|
Operating income
(loss)
|
|
|
|
94,767
|
|
14,871
|
|
21,400
|
|
23,095
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
- Interest
income
|
|
|
|
5,128
|
|
805
|
|
2,145
|
|
1,106
|
- Interest
expense
|
|
|
|
(5,054)
|
|
(793)
|
|
(8,490)
|
|
(8,892)
|
- Other income
(expense), net
|
|
|
|
390
|
|
61
|
|
(1,560)
|
|
(1,621)
|
Total other income
(expense)
|
|
|
|
464
|
|
73
|
|
(7,905)
|
|
(9,407)
|
Income (loss) before
provision for income taxes
|
|
|
|
95,231
|
|
14,944
|
|
13,495
|
|
13,688
|
Income tax (expense)
benefit
|
|
|
|
(6,018)
|
|
(944)
|
|
6,115
|
|
(2,325)
|
Net income
(loss)
|
|
|
|
89,213
|
|
14,000
|
|
19,610
|
|
11,363
|
Net income (loss)
attributable to noncontrolling interests
|
|
|
|
0
|
|
0
|
|
—
|
|
—
|
Net income (loss)
attributable to the Company
|
|
|
|
89,213
|
|
14,000
|
|
19,610
|
|
11,363
|
Other comprehensive
income (loss):
|
|
|
|
|
|
|
|
|
|
|
- Foreign currency
translation adjustments attributable to noncontrolling
interest
|
|
|
|
0
|
|
0
|
|
—
|
|
—
|
- Foreign currency
translation adjustments attributable to the Company
|
|
|
|
0
|
|
0
|
|
—
|
|
—
|
Comprehensive income
(loss) attributable to non-controlling interest
|
|
|
|
0
|
|
0
|
|
—
|
|
—
|
Comprehensive income
(loss) attribute to the Company
|
|
|
|
89,213
|
|
14,000
|
|
19,610
|
|
11,363
|
Net earnings (loss) per
share, Basic and diluted
|
|
|
|
27.32
|
|
4.29
|
|
6.00
|
|
3.48
|
Weighted average number
of ordinary shares, Basic and diluted
|
|
|
|
3,265,837
|
|
3,265,837
|
|
3,265,837
|
|
3,265,837
|
FUWEI FILMS
(HOLDINGS) CO., LTD, and SUBSIDIARIES
|
|
CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
For the Years
Ended December 31, 2021, 2020 and 2019
|
(Amounts in
thousands)
|
|
|
|
The Years Ended December 31,
|
|
|
2021
|
|
2020
|
|
2019
|
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
Cash flow from
operating activities
|
|
|
|
|
|
|
|
|
Net income
(loss)
|
|
89,213
|
|
14,000
|
|
19,610
|
|
11,363
|
Adjustments to
reconcile net income (loss) to net cash provided by (used in)
operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Loss on assets held
for sale impairment
|
|
0
|
|
0
|
|
37,951
|
|
—
|
- Depreciation of
property, plant, and equipment
|
|
12,365
|
|
1,940
|
|
41,722
|
|
41,451
|
- Amortization of
intangible assets
|
|
534
|
|
84
|
|
534
|
|
534
|
- Deferred income taxes
(benefit)
|
|
6,018
|
|
944
|
|
(6,115)
|
|
2,325
|
- Bad debt (recovery)
expense
|
|
(1,230)
|
|
(193)
|
|
578
|
|
(1,014)
|
- Inventory
provision
|
|
(431)
|
|
(68)
|
|
267
|
|
1,489
|
Changes in operating
assets and liabilities
|
|
|
|
|
|
|
|
|
- Investment income
recorded on Fuwei Holdings' book
|
|
0
|
|
0
|
|
—
|
|
—
|
- Accounts and bills
receivable
|
|
3,470
|
|
545
|
|
(5,086)
|
|
(3,319)
|
-
Inventories
|
|
(9,589)
|
|
(1,505)
|
|
(2,119)
|
|
(399)
|
- Advance to
suppliers
|
|
352
|
|
55
|
|
(2,009)
|
|
(583)
|
- Prepaid expenses and
other current assets
|
|
(96)
|
|
(15)
|
|
(35)
|
|
10
|
- Accounts
payable
|
|
(3,114)
|
|
(489)
|
|
6,198
|
|
(1,217)
|
- Accrued expenses and
other payables
|
|
(15,273)
|
|
(2,398)
|
|
21,938
|
|
(302)
|
- Advance from
customers
|
|
(1,625)
|
|
(255)
|
|
4,093
|
|
3,344
|
- Tax
payable
|
|
(645)
|
|
(101)
|
|
9
|
|
684
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) operating activities
|
|
79,949
|
|
12,544
|
|
117,536
|
|
54,366
|
|
|
|
|
|
|
|
|
|
Cash flow from
investing activities
|
|
|
|
|
|
|
|
|
Purchases of property,
plant, and equipment
|
|
(7,986)
|
|
(1,253)
|
|
(11,257)
|
|
(12,925)
|
Advanced to suppliers -
non-current
|
|
1,542
|
|
242
|
|
—
|
|
—
|
Amount change in
construction in progress
|
|
0
|
|
0
|
|
—
|
|
366
|
Proceeds from sale of
property, plant, and equipment
|
|
122,919
|
|
19,289
|
|
—
|
|
—
|
Deposit for
purchase
|
|
0
|
|
0
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
Net cash used in
(provided by) investing activities
|
|
116,475
|
|
18,278
|
|
(11,257)
|
|
(12,559)
|
|
|
|
|
|
|
|
|
|
Cash flow from
financing activities
|
|
|
|
|
|
|
|
|
Principal payments of
bank loans
|
|
0
|
|
0
|
|
—
|
|
—
|
Proceeds from
short-term bank loans
|
|
0
|
|
0
|
|
—
|
|
50
|
Proceeds from related
party
|
|
(73,571)
|
|
(11,545)
|
|
(45,726)
|
|
4,606
|
Payment of capital
lease obligation
|
|
0
|
|
0
|
|
—
|
|
—
|
Change in notes
payable
|
|
35,126
|
|
5,512
|
|
(26,000)
|
|
(7,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) financing activities
|
|
(38,445)
|
|
(6,033)
|
|
(71,726)
|
|
(2,344)
|
|
|
|
|
|
|
|
|
|
Effect of foreign
exchange rate changes
|
|
0
|
|
445
|
|
(1)
|
|
—
|
|
|
|
|
|
|
|
|
|
Net increase (decrease)
in cash and cash equivalent, restricted cash
|
|
157,979
|
|
25,234
|
|
34,552
|
|
39,463
|
|
|
|
|
|
|
|
|
|
Cash and cash
equivalent, and restricted cash
|
|
|
|
|
|
|
|
|
At beginning of the
period/year
|
|
120,923
|
|
18,532
|
|
86,371
|
|
46,908
|
At end of the
period/year
|
|
278,902
|
|
43,766
|
|
120,923
|
|
86,371
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTARY
DISCLOSURE:
|
|
|
|
|
|
|
|
|
Interest
paid
|
|
5,054
|
|
793
|
|
8,490
|
|
8,892
|
Income tax
paid
|
|
0
|
|
0
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTARY
SCHEDULE OF NONCASH INVESTING AND FINANCIAL
ACTIVITIES:
|
|
|
|
|
|
|
|
|
Account payable for
plant and equipment:
|
|
1,010
|
|
158
|
|
1,010
|
|
1,010
|
Obligations for
acquired equipment under capital lease:
|
|
0
|
|
0
|
|
—
|
|
—
|
View original
content:https://www.prnewswire.com/news-releases/fuwei-films-announces-fourth-quarter-and-full-year-2021-financial-results-301535764.html
SOURCE Fuwei Films